Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Clinical trial NCT00780494 · COMPLETED

Trial details

NCT number: NCT00780494
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Cancer Gastric (Stomach) Cancer Neoplasm of Cardioesophageal Junction Gastrointestinal Stromal Tumor (GIST)

Start date: 2009-02-01
Primary completion: 2017-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.